Choksi Laboratories Board to Consider Q2 Results on 14th Nov'26
Choksi Laboratories Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Choksi Laboratories Board to Consider Q2 Results on 14th Nov'26 Choksi Laboratories Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company's trading window for dealing in its securities, which has been closed since 1st Oct'26, will reopen 48 hours following the declaration of the financial results for all designated and connected persons.
Original exchange filing (PDF)
More announcements from Choksi Laboratories Ltd
- Considered and approved the Unaudited Financial Results for the quarter and half year ended on 30th September,2026 along with the Limited Review Report 路 14 Nov 2026
- 1. Considered and approved the Unaudited Financial Results for the Quarter and Half Year ended on 30th September, 2026 along with the Limited review report; 2. The Board has also discussed .... 路 14 Nov 2026
- Intimation under Regulation 30 is attached herewith. 路 03 Nov 2026
- We are enclosing herewith clarification on delay in submission with respect to proceedings of EGM 路 22 Oct 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for .... 路 19 Oct 2026
- The voting result along with the scrutinizer report the e-voting and remote e-voting held at EGM of the company held on 17.10.2026. 路 19 Oct 2026
- Summary of proceedings of EGM enclosed herewith 路 18 Oct 2026
- Extra-Ordinary General Meeting of the company is scheduled to be held on Saturday, 17th October, 2026 at 12:30 p.m. through video conferencing/OAVM to transact the business as set out in .... 路 24 Sept 2026
